Literature DB >> 21849757

Interpregnancy body mass index changes and risk of stillbirth.

Valerie E Whiteman1, Luminita Crisan, Cheri McIntosh, A P Alio, Jingyi Duan, Phillip J Marty, Hamisu M Salihu.   

Abstract

BACKGROUND/AIMS: To examine the association between interpregnancy body mass index (BMI) change and stillbirth.
METHODS: Retrospective study using Missouri maternally linked cohort files (1978-2005). A total of 218,389 women were used in the analysis. BMI was classified as: underweight (<18.5), normal (18.5-24.9), overweight (25-29.9), or obese (≥30.0). Weight change was defined based on BMI category (i.e. normal-normal, normal-obese, etc.). Cox proportional hazard regression models were used to generate adjusted hazard ratios (HR) and 95% CI for the risk of stillbirth in the second pregnancy.
RESULTS: Significant findings were associated with interpregnancy BMI changes involving overweight mothers becoming obese (HR = 1.4, 95% CI 1.1-1.7), normal-weight mothers becoming overweight (HR = 1.2, 95% CI 1.0-1.4) or obese (HR = 1.5, 95% CI 1.1-2.1), or obese mothers maintaining their obesity status across the two pregnancies (HR = 1.4, 95% CI 1.2-1.7). Other weight change categories did not show significant risk elevation for stillbirth.
CONCLUSIONS: BMI change appears to play an important role in subsequent stillbirth risk.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21849757     DOI: 10.1159/000324375

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  9 in total

1.  Invited Commentary: The Causal Association Between Obesity and Stillbirth-Strengths and Limitations of the Consecutive-Pregnancies Approach.

Authors:  Jonathan M Snowden; Stephanie A Leonard
Journal:  Am J Epidemiol       Date:  2019-07-01       Impact factor: 4.897

2.  Short-term weight change and live birth among women with unexplained infertility and polycystic ovary syndrome undergoing ovulation induction.

Authors:  Wendy Vitek; Fangbai Sun; Kathleen M Hoeger; Nanette Santoro; Michael P Diamond; Heping Zhang; Richard S Legro
Journal:  Fertil Steril       Date:  2020-10-06       Impact factor: 7.329

Review 3.  Maternal adiposity--a determinant of perinatal and offspring outcomes?

Authors:  Debbie A Lawlor; Caroline Relton; Naveed Sattar; Scott M Nelson
Journal:  Nat Rev Endocrinol       Date:  2012-09-25       Impact factor: 43.330

4.  Association of Overweight and Obesity Development Between Pregnancies With Stillbirth and Infant Mortality in a Cohort of Multiparous Women.

Authors:  Ya-Hui Yu; Lisa M Bodnar; Katherine P Himes; Maria M Brooks; Ashley I Naimi
Journal:  Obstet Gynecol       Date:  2020-03       Impact factor: 7.623

5.  Inter-pregnancy weight change impacts placental weight and is associated with the risk of adverse pregnancy outcomes in the second pregnancy.

Authors:  Jacqueline M Wallace; Sohinee Bhattacharya; Doris M Campbell; Graham W Horgan
Journal:  BMC Pregnancy Childbirth       Date:  2014-01-22       Impact factor: 3.007

6.  Weight change across the start of three consecutive pregnancies and the risk of maternal morbidity and SGA birth at the second and third pregnancy.

Authors:  Jacqueline M Wallace; Sohinee Bhattacharya; Graham W Horgan
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

Review 7.  Recent advances in understanding the relationship between long- and short-term weight change and fertility.

Authors:  Audrey J Gaskins
Journal:  F1000Res       Date:  2018-10-26

8.  Inter-Pregnancy Weight Change and the Risk of Recurrent Pregnancy Complications.

Authors:  Jacqueline M Wallace; Sohinee Bhattacharya; Doris M Campbell; Graham W Horgan
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

9.  Does interpregnancy BMI change affect the risk of complications in the second pregnancy? Analysis of pooled data from Aberdeen, Finland and Malta.

Authors:  Dylan Peter McClurg; Mika Gissler; Miriam Gatt; Jacqueline Wallace; Sohinee Bhattacharya
Journal:  Int J Obes (Lond)       Date:  2021-10-04       Impact factor: 5.095

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.